These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35155990)

  • 1. The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation.
    Li X; Wang F; Li H; Richardson DD; Roush DJ
    Antib Ther; 2022 Jan; 5(1):42-54. PubMed ID: 35155990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Recombinantly-Expressed Hydrolytic Enzymes from Chinese Hamster Ovary Cells: Identification of Host Cell Proteins that Degrade Polysorbate.
    Kovner D; Yuk IH; Shen A; Li H; Graf T; Gupta S; Liu W; Tomlinson A
    J Pharm Sci; 2023 May; 112(5):1351-1363. PubMed ID: 36646283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the polysorbate degradation fingerprints and kinetics of lipases - how the activity of polysorbate degrading hydrolases is influenced by the assay and assay conditions.
    Glücklich N; Carle S; Buske J; Mäder K; Garidel P
    Eur J Pharm Sci; 2021 Nov; 166():105980. PubMed ID: 34419573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Characterization of Polysorbate-Degrading Enzymes in a Monoclonal Antibody Formulation.
    Graf T; Tomlinson A; Yuk IH; Kufer R; Spensberger B; Falkenstein R; Shen A; Li H; Duan D; Liu W; Wohlrab S; Edelmann F; Leiss M
    J Pharm Sci; 2021 Nov; 110(11):3558-3567. PubMed ID: 34224732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysorbate Degradation and Particle Formation in a High Concentration mAb: Formulation Strategies to Minimize Effect of Enzymatic Polysorbate Degradation.
    Roy I; Patel A; Kumar V; Nanda T; Assenberg R; Wuchner K; Amin K
    J Pharm Sci; 2021 Sep; 110(9):3313-3323. PubMed ID: 34077768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling Active Enzymes for Polysorbate Degradation in Biotherapeutics by Activity-Based Protein Profiling.
    Li X; Chandra D; Letarte S; Adam GC; Welch J; Yang RS; Rivera S; Bodea S; Dow A; Chi A; Strulson CA; Richardson DD
    Anal Chem; 2021 Jun; 93(23):8161-8169. PubMed ID: 34032423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways.
    Kerwin BA
    J Pharm Sci; 2008 Aug; 97(8):2924-35. PubMed ID: 17973307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.
    Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K
    Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysorbate degradation in biotherapeutic formulations: Identification and discussion of current root causes.
    Dwivedi M; Blech M; Presser I; Garidel P
    Int J Pharm; 2018 Dec; 552(1-2):422-436. PubMed ID: 30300706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of Polysorbate 20 by Sialate O-Acetylesterase in Monoclonal Antibody Formulations.
    Zhang S; Xiao H; Li N
    J Pharm Sci; 2021 Dec; 110(12):3866-3873. PubMed ID: 34487744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Polysorbate 80 Degradation by Liver Carboxylesterase in a Monoclonal Antibody Formulated Drug Substance at Early Stage Development.
    Zhang S; Xiao H; Molden R; Qiu H; Li N
    J Pharm Sci; 2020 Nov; 109(11):3300-3307. PubMed ID: 32721471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity-Based Protein Profiling Probe for the Detection of Enzymes Catalyzing Polysorbate Degradation.
    Liu GY; Nie S; Zheng X; Li N
    Anal Chem; 2022 Jun; 94(24):8625-8632. PubMed ID: 35679579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Polysorbate 80 Hydrolysis and Oxidation on the Aggregation of a Monoclonal Antibody.
    Larson NR; Wei Y; Prajapati I; Chakraborty A; Peters B; Kalonia C; Hudak S; Choudhary S; Esfandiary R; Dhar P; Schöneich C; Middaugh CR
    J Pharm Sci; 2020 Jan; 109(1):633-639. PubMed ID: 31758949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putative Phospholipase B-Like 2 is Not Responsible for Polysorbate Degradation in Monoclonal Antibody Drug Products.
    Zhang S; Xiao H; Goren M; Burakov D; Chen G; Li N; Tustian A; Adams B; Mattila J; Bak H
    J Pharm Sci; 2020 Sep; 109(9):2710-2718. PubMed ID: 32534029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled polysorbate 20 hydrolysis - A new approach to assess the impact of polysorbate 20 degradation on biopharmaceutical product quality in shortened time.
    Graf T; Abstiens K; Wedekind F; Elger C; Haindl M; Wurth C; Leiss M
    Eur J Pharm Biopharm; 2020 Jul; 152():318-326. PubMed ID: 32445968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in-depth examination of fatty acid solubility limits in biotherapeutic protein formulations containing polysorbate 20 and polysorbate 80.
    Glücklich N; Dwivedi M; Carle S; Buske J; Mäder K; Garidel P
    Int J Pharm; 2020 Dec; 591():119934. PubMed ID: 33059015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acidic and alkaline hydrolysis of polysorbates under aqueous conditions: Towards understanding polysorbate degradation in biopharmaceutical formulations.
    Dwivedi M; Buske J; Haemmerling F; Blech M; Garidel P
    Eur J Pharm Sci; 2020 Mar; 144():105211. PubMed ID: 31931121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasensitive Quantification Method for Understanding Biologically Relevant Concentrations of Host Cell Proteins in Therapeutics.
    Zhang S; Zhao B; Adaniya S; Xiao H; Li N
    Anal Chem; 2023 Apr; 95(14):6002-6008. PubMed ID: 36977129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Characterization of Polysorbate.
    Zhang S; Xiao H; Li N
    Curr Protoc; 2022 Jul; 2(7):e489. PubMed ID: 35857882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design to biologics development: The polysorbates point of view.
    Brovč EV; Mravljak J; Šink R; Pajk S
    Int J Pharm; 2020 May; 581():119285. PubMed ID: 32240804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.